TEMAZEPAM - AN OVERVIEW

Coadministration with CYP3A4 substrates, specifically those with a slim therapeutic index, can result in diminished concentrations and lack of efficacy. If not able to steer clear of coadministration, watch CYP3A4 substrate ranges and change dose as required.bremelanotide will reduce the extent or impact of triazolam by Other (see remark). Stay awa